全球聚乙二醇化市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球聚乙二醇化市场需求预计将从2023年的20.3亿美元达到2032年近58亿美元的市场规模，2024-2032年研究期间复合年增长率为12.36%。

聚乙二醇化（或聚乙二醇化）是将聚乙二醇（PEG，在药学中也称为聚乙二醇）聚合物链以共价和非共价方式连接或合併到分子和宏观结构（例如药物、治疗性蛋白质或囊泡）的过程。聚乙二醇化通常是透过将目标分子与反应性聚乙二醇衍生物一起孵育来完成。 PEG 与药物或治疗蛋白的共价连接可以「隐藏」宿主免疫系统的药剂（降低免疫原性和抗原性）并增强其流体动力学尺寸（溶液中的尺寸），从而延长其循环持续时间通过减少肾臟清除率。疏水性药物和蛋白质也可以进行聚乙二醇化，使其具有水溶性。

市场动态

製药和生物製药公司研发投资的增加、生物製品行业的扩张、生活方式疾病盛行率的上升以及对改善蛋白质稳定性和循环半衰期的关注和认识的提高预计将推动市场成长。此外，随着感染慢性病的人数增加，聚乙二醇化市场将因聚乙二醇化蛋白用于治疗各种慢性病的使用增加而受到推动。聚乙二醇化分子具有许多优点，包括更长的半衰期、更低的毒性、更低的免疫原性和增强的蛋白水解保护，所有这些都有助于市场的持续扩张。但另一方面，聚乙二醇化製程成本的上升和某些药物的专利到期预计将抑制市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球聚乙二醇化市场的各个细分市场进行了包容性评估。聚乙二醇化产业的成长和趋势为本研究提供了整体方法。

市场区隔

聚乙二醇化市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品和服务

• 耗材
• 服务

按类型

• 群落刺激因子
• 干扰素
• 促红血球生成素
• 重组因子VII
• 其他的

按申请

• 癌症
• 自体免疫疾病
• 肝炎
• 多发性硬化症
• 血友病
• 胃肠道疾病
• 其他的

按最终用户

• 製药与生物技术公司
• 合约研究组织
• 学术及研究机构
• 聚乙二醇化蛋白质

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲聚乙二醇化市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。聚乙二醇化市场的主要参与者包括Thermo Fisher Scientific Inc.、Abcam Plc、Enzon Pharmaceuticals Inc.、Merck KGaA、Celares GmbH、Profacgen、Creative PEGworks、NOF America Corp.、Aurigene Pharmaceutical Services Ltd.、Laysan Bio Inc. 。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：聚乙二醇化 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品和服务分類的市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球聚乙二醇化市场分析：依产品与服务分类

• 按产品和服务分類的概述
• 按产品和服务进行历史和预测资料分析
• 耗材
• 服务

第 6 章：全球聚乙二醇化市场分析：按类型

• 按类型概述
• 按类型分析历史和预测数据
• 群落刺激因子
• 干扰素
• 促红血球生成素
• 重组因子VII
• 其他的

第 7 章：全球聚乙二醇化市场分析：依应用分类

• 概述：按应用
• 历史与预测资料分析：按应用分类
• 癌症
• 自体免疫疾病
• 肝炎
• 多发性硬化症
• 血友病
• 胃肠道疾病
• 其他的

第 8 章：全球聚乙二醇化市场分析：依最终用户分类

• 最终用户概述
• 最终用户的历史和预测数据分析
• 製药与生物技术公司
• 合约研究组织
• 学术及研究机构
• 聚乙二醇化蛋白质

第 9 章：全球聚乙二醇化市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：聚乙二醇化公司的竞争格局

• 聚乙二醇化市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Thermo Fisher Scientific Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Abcam Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Enzon Pharmaceuticals Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merck KGaA
• 公司概况
• 公司收入
• 产品
• 最新动态
• Celares GmbH
• 公司概况
• 公司收入
• 产品
• 最新动态
• Profacgen
• 公司概况
• 公司收入
• 产品
• 最新动态
• Creative PEGworks
• 公司概况
• 公司收入
• 产品
• 最新动态
• NOF America Corp.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Aurigene Pharmaceutical Services Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Laysan Bio Inc
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for PEGylation Market is presumed to reach the market size of nearly USD 5.8 Billion by 2032 from USD 2.03 Billion in 2023 with a CAGR of 12.36% under the study period 2024-2032.

PEGylation (or pegylation) is the process of attaching or amalgamating polyethylene glycol (PEG, also known as macrogol in pharmacy) polymer chains to molecules and macrostructures, such as medication, therapeutic protein, or vesicle, in both covalent and non-covalent ways. PEGylation is commonly accomplished by incubating the target molecule with a reactive PEG derivative. The covalent attachment of PEG to a medication or therapeutic protein can ''''hide'''' the agent from the host's immune system (reduce immunogenicity and antigenicity) and enhance its hydrodynamic size (size in solution), which extends its circulation duration by reducing renal clearance. Hydrophobic medicines and proteins can also be PEGylated to make them water-soluble.

MARKET DYNAMICS

Increased R&D investments by pharmaceutical and biopharmaceutical companies, expansion in the biologics industry, rising prevalence of lifestyle illness, and increased attention and awareness on improving protein stability and circulation half-life are projected to drive market growth. Furthermore, as the number of people infected with chronic diseases rise, the PEGylation market will be fueled by the increased usage of PEGylated protein to treat various chronic diseases. PEGylated molecules provide many advantages, including a longer half-life, decreased toxicity, lower immunogenicity, and increased proteolytic protection, all contribute to the market's continued expansion. But on the other side, rising PEGylation process costs and the patent expiration of certain medications are expected to stifle market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of PEGylation. The growth and trends of PEGylation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the PEGylation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

• Consumables
• Services

By Type

• Colony-stimulating Factor
• Interferons
• Erythropoietin
• Recombinant Factor VII
• Others

By Application

• Cancer
• Autoimmune Diseases
• Hepatitis
• Multiple Sclerosis
• Hemophilia
• Gastrointestinal Disorders
• Others

By End-user

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes
• PEGylated Proteins

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the PEGylation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the PEGylation market include Thermo Fisher Scientific Inc., Abcam Plc, Enzon Pharmaceuticals Inc., Merck KGaA, Celares GmbH, Profacgen, Creative PEGworks, NOF America Corp., Aurigene Pharmaceutical Services Ltd., Laysan Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. PEGYLATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product & Services
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEGYLATION MARKET ANALYSIS BY PRODUCT & SERVICES

• 5.1. Overview By Product & Services
• 5.2. Historical and Forecast Data Analysis By Product & Services
• 5.3. Consumables Historic and Forecast Sales By Regions
• 5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL PEGYLATION MARKET ANALYSIS BY TYPE

• 6.1. Overview By Type
• 6.2. Historical and Forecast Data Analysis By Type
• 6.3. Colony-stimulating Factor Historic and Forecast Sales By Regions
• 6.4. Interferons Historic and Forecast Sales By Regions
• 6.5. Erythropoietin Historic and Forecast Sales By Regions
• 6.6. Recombinant Factor VII Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PEGYLATION MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Cancer Historic and Forecast Sales By Regions
• 7.4. Autoimmune Diseases Historic and Forecast Sales By Regions
• 7.5. Hepatitis Historic and Forecast Sales By Regions
• 7.6. Multiple Sclerosis Historic and Forecast Sales By Regions
• 7.7. Hemophilia Historic and Forecast Sales By Regions
• 7.8. Gastrointestinal Disorders Historic and Forecast Sales By Regions
• 7.9. Others Historic and Forecast Sales By Regions

8. GLOBAL PEGYLATION MARKET ANALYSIS BY END-USER

• 8.1. Overview By End-user
• 8.2. Historical and Forecast Data Analysis By End-user
• 8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
• 8.4. Contract Research Organizations Historic and Forecast Sales By Regions
• 8.5. Academic & Research Institutes Historic and Forecast Sales By Regions
• 8.6. PEGylated Proteins Historic and Forecast Sales By Regions

9. GLOBAL PEGYLATION MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEGYLATION COMPANIES

• 10.1. PEGylation Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF PEGYLATION INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Thermo Fisher Scientific Inc.
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Abcam Plc
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Enzon Pharmaceuticals Inc.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Merck KGaA
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Celares GmbH
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Profacgen
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Creative PEGworks
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. NOF America Corp.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Aurigene Pharmaceutical Services Ltd.
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Laysan Bio Inc
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product & Services (USD MN)
• Consumables Market Sales By Geography (USD MN)
• Services Market Sales By Geography (USD MN)
• Analysis By Type (USD MN)
• Colony-stimulating Factor Market Sales By Geography (USD MN)
• Interferons Market Sales By Geography (USD MN)
• Erythropoietin Market Sales By Geography (USD MN)
• Recombinant Factor VII Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Autoimmune Diseases Market Sales By Geography (USD MN)
• Hepatitis Market Sales By Geography (USD MN)
• Multiple Sclerosis Market Sales By Geography (USD MN)
• Hemophilia Market Sales By Geography (USD MN)
• Gastrointestinal Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End-user (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
• Contract Research Organizations Market Sales By Geography (USD MN)
• Academic & Research Institutes Market Sales By Geography (USD MN)
• PEGylated Proteins Market Sales By Geography (USD MN)
• Global PEGylation Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of PEGylation Report
• Market Research Process
• Market Research Methodology
• Global PEGylation Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product & Services
• Market Attractiveness Analysis By Type
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-user
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product & Services (USD MN)
• Consumables Market Sales By Geography (USD MN)
• Services Market Sales By Geography (USD MN)
• Global Market Analysis By Type (USD MN)
• Colony-stimulating Factor Market Sales By Geography (USD MN)
• Interferons Market Sales By Geography (USD MN)
• Erythropoietin Market Sales By Geography (USD MN)
• Recombinant Factor VII Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Autoimmune Diseases Market Sales By Geography (USD MN)
• Hepatitis Market Sales By Geography (USD MN)
• Multiple Sclerosis Market Sales By Geography (USD MN)
• Hemophilia Market Sales By Geography (USD MN)
• Gastrointestinal Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End-user (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
• Contract Research Organizations Market Sales By Geography (USD MN)
• Academic & Research Institutes Market Sales By Geography (USD MN)
• PEGylated Proteins Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.